En
It
De
日本語
中文
Es
The fast-evolving biotech drug market is strongly influencing the demand for glass primary packaging.
For instance, as the intravenous administration of monoclonal antibodies in hospitals or clinics remains an expensive procedure that can generate inconvenience and discomfort for patients, several biopharma companies have started re-formulating their IV mAbs for large-volume, subcutaneous (SQ) delivery. This shift reduces injection times from hours to minutes and enables the adoption of self-administration treatments using wearable injectors.
Stevanato Group has developed large-volume glass barrels (5mL up to 50mL) suited for the application of viscous biologics.
Large-volume cartridges can be supplied in bulk configuration or in EZ-fill® nest and tub, steam‑sterilized and ready-to-fill. Thanks to our range of EZ-fill® cartridges, we have become a trusted partner in many wearable programs.
| Tray | Nest & Tub | |||
|---|---|---|---|---|
| 5 mL | - | - |
Pre-capped |
42 |
| 10 mL | - | - |
Pre-capped |
42 |
| 20 mL | - | - |
Pre-capped |
36 |
By collaborating with customers and suppliers, our drug delivery cartridges are designed to be easily integrated into wearable devices that can release the medicament over a longer period of time.
They give device designers a wide choice of customization parameters, including the container length, diameter, volume, neck, flange design and material choice for the stopper and plunger.
Reduced glass-to-glass contact during forming process to maximize mechanical resistance when paired with drug delivery systems
Optimized siliconization options depending on formats and device application
Range of closures for RTU containers for increased design flexibility and predictable drug interaction
Extensively customizable, the dimensions can be tailored precisely upon request to fit your drug delivery device and application.
Designed for injecting biologics over a long time period.
High-value biologics for the treatment of conditions such as cancer, Parkinson’s, and autoimmune diseases.